AN2 Therapeutics, Inc. (ANTX): DEFA14A filed Apr 22, 2026

Form type

DEFA14A

Filing date

Apr 22, 2026

Accession number

0001193125-26-170321

Filer

AN2 Therapeutics, Inc. (CIK 1880438)